These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8212819)

  • 1. Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers.
    Jertborn M; Svennerholm AM; Holmgren J
    Vaccine; 1993; 11(10):1007-12. PubMed ID: 8212819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers.
    Jertborn M; Svennerholm AM; Holmgren J
    Vaccine; 1994 Sep; 12(12):1078-82. PubMed ID: 7998416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers.
    Jertborn M; Svennerholm AM; Holmgren J
    Vaccine; 1992; 10(2):130-2. PubMed ID: 1539466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine.
    Jertborn M; Svennerholm AM; Holmgren J
    Vaccine; 1996 Oct; 14(15):1459-65. PubMed ID: 8994322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG and IgA subclass distribution of antitoxin antibody responses after oral cholera vaccination or cholera disease.
    Jertborn M; Svennerholm AM; Holmgren J
    Int Arch Allergy Appl Immunol; 1988; 85(3):358-63. PubMed ID: 3350611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
    Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
    J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine specific immune response to an inactivated oral cholera vaccine and EPI vaccines in a high and low arsenic area in Bangladeshi children.
    Saha A; Chowdhury MI; Nazim M; Alam MM; Ahmed T; Hossain MB; Hore SK; Sultana GN; Svennerholm AM; Qadri F
    Vaccine; 2013 Jan; 31(4):647-52. PubMed ID: 23200936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.
    Alam MM; Riyadh MA; Fatema K; Rahman MA; Akhtar N; Ahmed T; Chowdhury MI; Chowdhury F; Calderwood SB; Harris JB; Ryan ET; Qadri F
    Clin Vaccine Immunol; 2011 May; 18(5):844-50. PubMed ID: 21346055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country.
    Akhtar M; Qadri F; Bhuiyan TR; Akter S; Rafique TA; Khan A; Islam LN; Saha A; Svennerholm AM; Lundgren A
    Vaccine; 2017 Jan; 35(2):321-328. PubMed ID: 27916412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of local and systemic immune responses to an oral cholera vaccine given alone or together with acetylcysteine.
    Kilhamn J; Jertborn M; Svennerholm AM
    Clin Diagn Lab Immunol; 1998 Mar; 5(2):247-50. PubMed ID: 9521151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin.
    Migasena S; Desakorn V; Suntharasamai P; Pitisuttitham P; Prayurahong B; Supanaranond W; Black RE
    Infect Immun; 1989 Jan; 57(1):117-20. PubMed ID: 2909484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease.
    Jertborn M; Svennerholm AM; Holmgren J
    J Clin Microbiol; 1986 Aug; 24(2):203-9. PubMed ID: 3528211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children.
    Taylor DN; Cárdenas V; Perez J; Puga R; Svennerholm AM
    Am J Trop Med Hyg; 1999 Dec; 61(6):869-73. PubMed ID: 10674661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
    Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
    Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in plasma viral load after oral cholera immunization of HIV-infected subjects.
    Ortigão-de-Sampaio MB; Shattock RJ; Hayes P; Griffin GE; Linhares-de-Carvalho MI; Ponce de Leon A; Lewis DJ; Castello-Branco LR
    AIDS; 1998 Oct; 12(14):F145-50. PubMed ID: 9792370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine.
    Hall ER; Wierzba TF; Ahrén C; Rao MR; Bassily S; Francis W; Girgis FY; Safwat M; Lee YJ; Svennerholm AM; Clemens JD; Savarino SJ
    Infect Immun; 2001 May; 69(5):2853-7. PubMed ID: 11292698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of local and systemic immune responses after vaginal immunization with recombinant cholera toxin B subunit in humans.
    Wassen L; Jertborn M
    Clin Diagn Lab Immunol; 2005 Mar; 12(3):447-52. PubMed ID: 15753258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation.
    Karlsen TH; Sommerfelt H; Klomstad S; Andersen PK; Strand TA; Ulvik RJ; Ahrén C; Grewal HM
    Infect Immun; 2003 Jul; 71(7):3909-13. PubMed ID: 12819076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut mucosal, salivary and serum antitoxic and antibacterial antibody responses in Swedes after oral immunization with B subunit-whole cell cholera vaccine.
    Jertborn M; Svennerholm AM; Holmgren J
    Int Arch Allergy Appl Immunol; 1984; 75(1):38-43. PubMed ID: 6746103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.